Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

Stephen R Marder; Larry Alphs; Ion-George Anghelescu; Celso Arango; Thomas RE Barnes; Ivo Caers; David G Daniel; Eduardo Dunayevich; W Wolfgang Fleischhacker; George Garibaldi; Michael F Green; Philip D Harvey; Rene S Kahn; John M Kane; Richard SE Keefe; Bruce Kinon; Stefan Leucht; Jean-Pierre Lindenmayer; Anil K Malhotra; Virginia Stauffer; Daniel Umbricht; Keith Wesnes; Shitij Kapur; Jonathan Rabinowitz

Journal article

Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

Stephen R Marder, Larry Alphs, Ion-George Anghelescu, Celso Arango, Thomas RE Barnes, Ivo Caers, David G Daniel, Eduardo Dunayevich, W Wolfgang Fleischhacker, George Garibaldi, Michael F Green, Philip D Harvey, Rene S Kahn, John M Kane, Richard SE Keefe, Bruce Kinon, Stefan Leucht, Jean-Pierre Lindenmayer, Anil K Malhotra, Virginia Stauffer Show all

Schizophrenia Research | ELSEVIER SCIENCE BV | Published : 2013

DOI: 10.1016/j.schres.2013.07.058

University of Melbourne Researchers

Shitij Kapur Author Medicine, Dentistry and Health Sciences

Grants

Awarded by Medical Research Council

Funding Acknowledgements

The meeting was supported by a grant from the NEWMEDS program and Innovative Medicines Initiative Joint Undertaking (IMI JU) by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union.